
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on April 23, 2025
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
8,081 cr
Turnover Ratio
16.09%
Expense Ratio
0.91%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 2.10%
- 1Y: 19.87%
- 3M: 0.43%
- 3Y: 20.91%
- 6M: -0.93%
- 5Y: 23.72%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
478.369 | 24.37% | 3,611 cr | 0.9% | - |
Other plans of Nippon India Pharma